Clinical and therapeutic outcomes of pediatric pituitary adenomas: a single pituitary center experience
- PMID: 37779166
- DOI: 10.1007/s12020-023-03523-3
Clinical and therapeutic outcomes of pediatric pituitary adenomas: a single pituitary center experience
Abstract
Purpose: Pediatric pituitary adenomas (PPA) are rare. Although PPAs are mostly benign, they can be challenging to manage. Most studies evaluating PPA are based on surgical series. We aimed to present the clinical features, hormonal status and treatment outcomes of children with PPA managed in a joint neuroendocrine setting.
Methods: In this single-center study, demographic, clinical and endocrinological data of patients under 19 years old who were followed up with the diagnosis of PPA between 2002-2022 were retrospectively reviewed. A total of 21 studies published in the past 20 years were also systematically reviewed.
Results: There were 79 patients (52 girls, 27 boys) with a median age of 15.8 years. Median follow-up time was 30 months. The most common adenoma subtype was non-functioning adenoma (NFA) (35.5%), followed by prolactinoma (29.1%), corticotropinoma (21.5%), and somatotropinoma (13.9%), respectively. The frequency of micro and macroadenomas was almost equal while 38% of all adenomas were invasive. Headache, visual impairment and menstrual irregularity were the most common complaints, while the most common hormonal deficiency at diagnosis was central hypothyroidism (31.6%), followed by hypogonadotropic hypogonadism (22.7%), growth hormone deficiency (15.2%) and central adrenal insufficiency (11.4%), respectively. Fifty patients (63.2%) underwent endoscopic endonasal transsphenoidal surgery (EETS). Following the surgery, impaired endocrine functions recovered at a rate of 62% while permanent central diabetes insipidus was observed in 6%, and new onset hypopituitarism developed in 4%.
Conclusion: NFA was more common in this cohort than in previous reports, which is one of the largest PPA series in the literature. Hormonal disorders, which were common at the time of diagnosis, were largely resolved with appropriate endocrinological and surgical approaches, while the rate of pituitary hormonal deficiencies after EETS was relatively low. Therefore, we recommend that children with PPA be managed in the setting of a high-volume pituitary center to provide long-term low morbidity.
Keywords: Endoscopic endonasal transsphenoidal surgery; Neuroendocrinology; Pediatric; Pituitary adenoma.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.Childs Nerv Syst. 2019 Nov;35(11):2119-2126. doi: 10.1007/s00381-019-04179-z. Epub 2019 May 11. Childs Nerv Syst. 2019. PMID: 31079182
-
Pediatric pituitary adenomas are more aggressive, more likely to be hormone producing and are more difficult to cure than adult pituitary adenomas: case series and systematic literature review.Childs Nerv Syst. 2022 Apr;38(4):729-738. doi: 10.1007/s00381-022-05445-3. Epub 2022 Jan 19. Childs Nerv Syst. 2022. PMID: 35048170
-
Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.J Neurosurg. 2016 Mar;124(3):589-95. doi: 10.3171/2015.1.JNS141543. Epub 2015 Aug 7. J Neurosurg. 2016. PMID: 26252454
-
Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience.Croat Med J. 2012 Jun;53(3):224-33. doi: 10.3325/cmj.2012.53.224. Croat Med J. 2012. PMID: 22661135 Free PMC article.
-
Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.World Neurosurg. 2021 May;149:e1043-e1055. doi: 10.1016/j.wneu.2021.01.019. Epub 2021 Jan 29. World Neurosurg. 2021. PMID: 33524611 Review.
Cited by
-
Clinical characteristics and management of adipsic arginine vasopressin deficiency in children and adolescents with sellar germ cell tumors.Eur J Pediatr. 2024 Dec;183(12):5279-5289. doi: 10.1007/s00431-024-05803-0. Epub 2024 Oct 9. Eur J Pediatr. 2024. PMID: 39382648
-
Etiology, presentation, and outcomes of hyperprolactinemia due to pituitary masses in children and adolescents.Endocrine. 2025 May;88(2):553-563. doi: 10.1007/s12020-025-04176-0. Epub 2025 Feb 2. Endocrine. 2025. PMID: 39893604
-
Clinical parameters and postoperative outcomes of pituitary adenomas in children: Analysis according to size of adenomas and adopted surgical procedures.Mol Clin Oncol. 2024 Oct 18;21(6):94. doi: 10.3892/mco.2024.2792. eCollection 2024 Dec. Mol Clin Oncol. 2024. PMID: 39484285 Free PMC article.
-
Hyperprolactinemia in children and adolescents: clinical characteristics and etiological spectrum.Eur J Pediatr. 2025 May 28;184(6):366. doi: 10.1007/s00431-025-06200-x. Eur J Pediatr. 2025. PMID: 40437161
References
-
- E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33, 610–617 (1993) - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous